For those who've been tracking the weight loss medication landscape, late October 2025, marked a significant turning point. Eli Lilly and Walmart announced a collaboration that addresses two of the biggest obstacles standing between patients and GLP-1 medications: accessibility and cost. If the price of Zepbound has kept this treatment out of reach, or if…
